Zacks Research Upgrades CapsoVision (NASDAQ:CV) to Hold

CapsoVision (NASDAQ:CVGet Free Report) was upgraded by investment analysts at Zacks Research to a “hold” rating in a research note issued on Monday, Zacks reports.

A number of other brokerages have also weighed in on CV. Roth Capital started coverage on shares of CapsoVision in a report on Friday, August 28th. They issued a “buy” rating and a $9.00 price target for the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of CapsoVision in a report on Monday, June 29th. Finally, Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a research report on Friday, August 14th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $9.50.

Read Our Latest Research Report on CapsoVision

CapsoVision Stock Up 0.5%

Shares of NASDAQ:CV opened at $5.87 on Monday. The firm has a market cap of $293.78 million, a P/E ratio of -12.49 and a beta of -2.47. CapsoVision has a 12 month low of $3.43 and a 12 month high of $15.37. The company’s 50-day moving average price is $6.55 and its two-hundred day moving average price is $6.42.

CapsoVision (NASDAQ:CVGet Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.15) earnings per share for the quarter. CapsoVision had a negative return on equity of 177.85% and a negative net margin of 214.74%.The company had revenue of $3.64 million during the quarter. As a group, equities analysts predict that CapsoVision will post -0.56 earnings per share for the current fiscal year.

Insider Transactions at CapsoVision

In other CapsoVision news, major shareholder Eliyahou Et Al Harari bought 81,300 shares of the business’s stock in a transaction on Wednesday, July 8th. The shares were bought at an average cost of $6.09 per share, for a total transaction of $495,117.00. Following the transaction, the insider owned 3,282,051 shares in the company, valued at approximately $19,987,690.59. This trade represents a 2.54% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders have bought 156,218 shares of company stock worth $1,007,902. Corporate insiders own 2.30% of the company’s stock.

Institutional Investors Weigh In On CapsoVision

A number of institutional investors and hedge funds have recently modified their holdings of CV. BlackRock Inc. acquired a new position in CapsoVision in the second quarter valued at approximately $14,372,000. Geode Capital Management LLC grew its holdings in CapsoVision by 34.1% during the 4th quarter. Geode Capital Management LLC now owns 154,264 shares of the company’s stock worth $1,649,000 after acquiring an additional 39,231 shares during the period. State Street Corp grew its holdings in CapsoVision by 340.7% during the 4th quarter. State Street Corp now owns 85,929 shares of the company’s stock worth $919,000 after acquiring an additional 66,429 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of CapsoVision during the 2nd quarter valued at $569,000. Finally, Deutsche Bank AG bought a new stake in shares of CapsoVision during the 2nd quarter valued at $263,000.

About CapsoVision

(Get Free Report)

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.

Read More

Receive News & Ratings for CapsoVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CapsoVision and related companies with MarketBeat.com's FREE daily email newsletter.